5.77

0.86% 0.07

Decoy Therapeutics Inc (DCOY)

Overview News Price History Discussions Forecast

Decoy Therapeutics Inc stock is traded at $5.77, with a volume of 2,894. It is up +0.86% in the last 24 hours and up +0.00% over the past month. Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Previous Close:

$5.84

Open:

$5.8

24h Volume:

2,894

Relative Volume:

0.15

Market Cap:

$3.14M

Revenue:

Net Income/Loss:

$-12.52M

P/E Ratio:

-0.0477

EPS:

-120.8826

Net Cash Flow:

$-4.83M

1W Performance:

+6.32%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$5.80

$5.90

1-Week Range:

$5.47

$6.24

52-Week Range:

$5.15

$16.92

Decoy Therapeutics Inc Stock (DCOY) Company Profile

Name

Decoy Therapeutics Inc

Sector

Healthcare (1107)

Industry

Biotechnology (615)

Phone

346-772-0346

Address

2450 HOLCOMBE BLVD, HOUSTON

Employee

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

DCOY's Discussions on Twitter

Compare DCOY vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DCOY Decoy Therapeutics Inc	5.90	3.11M	0	-12.52M	-4.83M	-120.88
VRTX Vertex Pharmaceuticals Inc	426.38	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	722.87	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.61	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.68	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.81	33.06B	5.36B	287.73M	924.18M	2.5229

Decoy Therapeutics Inc Stock (DCOY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-23-26	Initiated	Ladenburg Thalmann	Buy
Apr-27-20	Initiated	Ladenburg Thalmann	Buy

Decoy Therapeutics Inc Stock (DCOY) Latest News

May 02, 2026

Decoy Therapeutics to implement 1-for-12 reverse stock split - Investing.com

May 02, 2026

Apr 27, 2026

Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston - BioSpace

Apr 27, 2026

Decoy Therapeutics (DCOY) Proxy Filing Summary - Quartr

Apr 27, 2026

Decoy Therapeutics Inc (FRA:FP11) Stock PDF (Updated: 2026/04/27) - GuruFocus

Apr 27, 2026

Decoy Therapeutics Showcases Novel Antiviral Therapies in Boston - Intellectia AI

Apr 27, 2026

Decoy Therapeutics Inc (FRA:FP11) Stock Earnings Transcripts - GuruFocus

Apr 27, 2026

Apr 26, 2026

Salarius Pharmaceuticals stock tumbles after announcing $7 million discounted public offering - MSN

Apr 26, 2026

Apr 23, 2026

Is Decoy (DCOY) stock gaining market share | Q3 2024: EPS Tops ViewsHot Market Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 10, 2026

DCOY Price Today: Decoy Therapeutics Inc. Stock Price, Quote & Chart - MEXC

Apr 10, 2026

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline - BioSpace

Apr 10, 2026

Apr 09, 2026

Transcript : Decoy Therapeutics Inc.Special Call - marketscreener.com

Apr 09, 2026

CEO Rick Pierce to outline Decoy's 2026 outlook in April 9 webcast - Stock Titan

Apr 09, 2026

Decoy Therapeutics outlines antiviral pipeline milestones By Investing.com - Investing.com South Africa

Apr 09, 2026

What is the volatility of Decoy (DCOY) Stock | Price at $5.84, Down 0.76%Index Investing - Newser

Apr 08, 2026

Apr 07, 2026

DCOY Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 07, 2026

Apr 06, 2026

Decoy Therapeutics to Participate in Virtual Investor Closing Be - GuruFocus

Apr 06, 2026

Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 - Finviz

Apr 06, 2026

Is Decoy (DCOY) Stock a Buy Now | DCOY Q4 Earnings: Beats Estimates by $25.32Recovery Stocks - Newser

Apr 06, 2026

Apr 03, 2026

Decoy Therapeutics Inc (STU:FP11) Stock Earnings Transcripts - GuruFocus

Apr 03, 2026

Decoy Therapeutics Inc (STU:FP11) Stock Price & 30 Year Financial Data - GuruFocus

Apr 03, 2026

Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Bitget

Apr 03, 2026

DCOY Stock Analysis: Decoy Therapeutics Inc. Slides 7.5% to $5.8 Key Biotech Trends - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 03, 2026

Apr 02, 2026